Cannabis Science, Inc. (CBIS) Launches New Corporate Advisory Structure

Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Company’s new corporate advisory structure and appoints new leadership for its Scientific Advisory and International Government Affairs Advisory Boards. Dr. Julius Garvey, a renowned vascular surgeon, has been named President of CBIS’ Scientific Advisory Board, and Mr. Jacques Walker, an experienced entrepreneur, has been named President of the Company’s International Government Affairs Advisory Board. Members of the two Corporate Advisory Boards will be announced shortly.

Dr. Garvey will lead the Scientific Advisory Board’s efforts to provide CBIS with guidance on the Company’s research and development activities, clinical trials, and technical collaborations in the markets where CBIS operates. Mr. Walker and members of the International Government Affairs Board will primarily focus on advising CBIS on its initiatives and collaborations with government entities, the general public and private-sector stakeholders worldwide.

“This is an exciting time for Cannabis Science,” stated Mr. Raymond C. Dabney, CBIS’ President, Chief Executive Officer (CEO), and Co-Founder. “Our research and development initiatives are well underway and are showing tremendous potential, and we also have a number of opportunities for growth through acquisitions and strategic partnerships. It’s time for the Company to better align our advisory boards in support of our corporate objectives and take advantage of the many talented people we have access to. Dr. Garvey has been involved with CBIS since 2015 and Mr. Walker since 2016. They both understand our business and should provide the leadership our advisory boards need as we move forward.”

Dr. Garvey joined Cannabis Science’s Scientific Advisory Board in 2015, and worked closely with the Company’s former Chief Medical Officer, Dr. Allen Herman. Tragically, Dr. Herman died after a brief illness in August. Over the last three years, Dr. Garvey has played an important role in support of the Company’s activities. Dr. Garvey has championed the Company’s initiatives and has provided CBIS with access to his extensive medical network in the U.S., Jamaica, and Africa. Dr. Garvey was a member of the CBIS delegation that visited Namibia and South Africa in 2016 to explore new business opportunities, and has subsequently visited CBIS’ project sites and collaborators in South Africa where CBIS is currently developing an initiative to cultivate, manufacture, and produce medical marijuana products. He also has participated in – and presented – at conferences on behalf of CBIS at Harvard Medical School and at the Constituency for Africa’s (CFA) annual Ronald H. Brown African Affairs Series in Washington, DC. CFA is one of the premier education and advocacy organizations focused on building support for Africa in the United States and throughout the African Diaspora. CBIS’ President, CEO, and Co-founder, Mr. Dabney, serves as a Member of CFA’s Board of Directors and Co-Chair of CFA’s African Healthcare Infrastructure Committee.

Julius Garvey, M.D., F.A.C.S, F.R.C.S.(C), F.I.C.S., F.A.C.Ph., F.A.C.C.W.S. is a Board-Certified surgeon specializing in the diagnosis and treatment of vascular diseases.  Dr. Garvey is the son of the late Marcus Garvey, founder of the Universal Negro Improvement Association and African Communities League, and an early proponent for civil rights and Pan-Africanism.

As the founder and Medical Director of Garvey Vascular Specialists, Dr. Garvey brings a wealth of experience and knowledge into his practice. His skill and proficiency provide his patients with an extensive range of expertise in the areas of arterial and venous diseases.  Dr. Garvey, a highly trained and credentialed surgeon, has held extensive academic appointments. He has worked as an Associate and Assistant Professor of Surgery at Albert Einstein College of Medicine in Bronx NY, Assistant Professor of Surgery, State University of NY at Stony Brook, NY, as well as Instructor in Surgery at both Albert Einstein College of Medicine in Bronx, NY and Columbia University College of Physicians & Surgeons, NY. Additionally, his hospital appointments are expansive. He has been an Attending Cardiothoracic Surgeon at Harlem Hospital Center in NY, NY and Montefiore Hospital in Bronx, NY, Associate Attending Head of Thoracic Surgery at the Montefiore Morrisania Affiliate in Bronx, NY, and Acting Program Director in the Division of Cardiothoracic Surgery at Long Island Jewish Medical Center in New Hyde Park, NY. He was also Chief of Vascular & Thoracic Surgery at Queens Hospital Center and is presently an attending surgeon on staff of the Long Island Jewish Medical Center.